Suppr超能文献

纤溶酶原是一种补体抑制剂。

Plasminogen is a complement inhibitor.

机构信息

Department of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology, Jena, Germany.

出版信息

J Biol Chem. 2012 May 25;287(22):18831-42. doi: 10.1074/jbc.M111.323287. Epub 2012 Mar 27.

Abstract

Plasminogen is a 92-kDa single chain glycoprotein that circulates in plasma as a zymogen and when converted to proteolytically active plasmin dissolves preformed fibrin clots and extracellular matrix components. Here, we characterize the role of plasmin(ogen) in the complement cascade. Plasminogen binds the central complement protein C3, the C3 cleavage products C3b and C3d, and C5. Plasminogen binds to C3, C3b, C3d, and C5 via lysine residues, and the interaction is ionic strength-dependent. Plasminogen and Factor H bind C3b; however, the two proteins bind to different sites and do not compete for binding. Plasminogen affects complement action in multiple ways. Plasminogen enhanced Factor I-mediated C3b degradation in the presence of the cofactor Factor H. Plasminogen when activated to plasmin inhibited complement as demonstrated by hemolytic assays using either rabbit or sheep erythrocytes. Similarly, plasmin either in the fluid phase or attached to surfaces inhibited complement that was activated via the alternative and classical pathways and cleaved C3b to fragments of 68, 40, 30, and 17 kDa. The C3b fragments generated by plasmin differ in size from those generated by the complement protease Factor I, suggesting that plasmin-mediated C3b cleavage fragments lack effector function. Plasmin also cleaved C5 to products of 65, 50, 30, and 25 kDa. Thus, plasmin(ogen) regulates both complement and coagulation, the two central cascade systems of a vertebrate organism. This complement-inhibitory activity of plasmin provides a new explanation why pathogenic microbes utilize plasmin(ogen) for immune evasion and tissue penetration.

摘要

纤溶酶原是一种 92kDa 的单链糖蛋白,以酶原的形式在血浆中循环,当转化为具有蛋白水解活性的纤溶酶时,溶解预先形成的纤维蛋白凝块和细胞外基质成分。在这里,我们描述了纤溶酶原(ogen)在补体级联中的作用。纤溶酶原结合中央补体蛋白 C3、C3 裂解产物 C3b 和 C3d 以及 C5。纤溶酶原通过赖氨酸残基结合 C3、C3b、C3d 和 C5,并且该相互作用依赖于离子强度。纤溶酶原和因子 H 结合 C3b;然而,这两种蛋白质结合到不同的位点,并且不竞争结合。纤溶酶原以多种方式影响补体作用。纤溶酶原增强了因子 I 在因子 H 存在时介导的 C3b 降解。纤溶酶原在被激活为纤溶酶时抑制补体,这可以通过使用兔或绵羊红细胞的溶血测定来证明。同样,纤溶酶无论是在液相中还是附着在表面上,都抑制通过替代途径和经典途径激活的补体,并将 C3b 切割成 68、40、30 和 17 kDa 的片段。纤溶酶介导的 C3b 裂解片段的大小与补体蛋白酶因子 I 产生的片段不同,这表明纤溶酶介导的 C3b 裂解片段缺乏效应功能。纤溶酶还将 C5 切割成 65、50、30 和 25 kDa 的产物。因此,纤溶酶原(ogen)调节补体和凝血,这是脊椎动物机体的两个中心级联系统。纤溶酶的这种补体抑制活性提供了一个新的解释,即为什么致病微生物利用纤溶酶原进行免疫逃避和组织穿透。

相似文献

1
Plasminogen is a complement inhibitor.纤溶酶原是一种补体抑制剂。
J Biol Chem. 2012 May 25;287(22):18831-42. doi: 10.1074/jbc.M111.323287. Epub 2012 Mar 27.

引用本文的文献

7
Immunity and Coagulation in COVID-19.新型冠状病毒肺炎中的免疫与凝血。
Int J Mol Sci. 2024 Oct 19;25(20):11267. doi: 10.3390/ijms252011267.
10
Immunity to fungi and vaccine considerations.真菌免疫与疫苗考虑因素。
Cell Host Microbe. 2024 Oct 9;32(10):1681-1690. doi: 10.1016/j.chom.2024.09.011.

本文引用的文献

2
Molecular intercommunication between the complement and coagulation systems.补体系统与凝血系统的分子相互通讯。
J Immunol. 2010 Nov 1;185(9):5628-36. doi: 10.4049/jimmunol.0903678. Epub 2010 Sep 24.
8
Complement regulators and inhibitory proteins.补体调节蛋白和抑制蛋白。
Nat Rev Immunol. 2009 Oct;9(10):729-40. doi: 10.1038/nri2620. Epub 2009 Sep 4.
9
Complement and immune defense: from innate immunity to human diseases.补体与免疫防御:从天然免疫到人类疾病。
Immunol Lett. 2009 Sep 22;126(1-2):1-7. doi: 10.1016/j.imlet.2009.07.005. Epub 2009 Jul 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验